Four New Jersey Universities together with the New Jersey Biotechnology Life Sciences Coalition are partnering with a large healthcare research and business consortium from the North of England, called the White Rose Health Innovation Partnership* (HIP). HIP has been created and funded to accelerate the translation of promising healthcare-related technologies, products, procedures and services toward clinical application. For more information about the NJ-HIP partnership, click here.

The first HIP activity is a baseline assessment of the most significant current barriers to innovation, the problems they are causing, and what it might take to remove them. Also of interest are experimental methods for removing these barriers. Based on the outcome of these surveys, technical, process, and other types of barriers will be clearly defined. HIP will prioritize the results of the surveys, provide opportunities to form collaborative teams and fund research to address the most critical barriers.

We invite your participation in the study.

In addition to these two online data collections, the project will conduct a series of focused interviews with decision leaders.

Results and analysis of the total baseline assessment plus news of the continuing activities of the NJ HIP project will be available at this website in the future. We appreciate your interest and participation as we work together to speed healthcare innovation.

* The White Rose University Consortium consists of the Universities of Leeds, Sheffield and York located in the North of England and maintains the largest teaching hospital in Europe. These Universities, together with the University of Bradford, and their industry partners (including Johnson & Johnson and Smith & Nephew), and the four New Jersey academic institutions are collaborating as the White Rose Health Innovation Partnership. This major two year project was competitively awarded and funded by the UK Higher Education Innovation Partnership Fund to use new methods to leverage the combined research strengths as a stimulus to more effective innovation in the healthcare marketplace. Link to White Rose University Consortium.

Stanley Underwood North, III, Esq.
SeidenWayne LLC
Two Penn Plaza
Newark, New Jersey 07105
973-491-3397